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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.04.029Objectives: An observational cohort study was conducted in infants less than 6
weeks of age undergoing intracardiac surgery to examine the predictive value of
serial postoperative lactate determination on survival and early childhood neurode-
velopment.
Methods: A total of 85 infants with congenital heart disease underwent intracardiac
surgery between 1996 and 1999. Differences in serial lactate concentrations after
surgery among 3 outcome groups were compared. The predictive value of plasma
lactate concentration on outcome (1) at discharge from initial hospitalization and (2)
18 to 24 months postnatal age was examined.
Results: Compared with survivors, the nonsurvivors had higher lactate concentra-
tions on admission to the pediatric intensive care unit at day 1 peak and area under
the curve of the lactate profile than those of adverse and intact survivors (all P 
.001, analysis of variance). Significant differences in the time for lactate concen-
trations to return to 2 mmol/L or less during the first postoperative day were
observed among the groups: nonsurvivors  adverse survivors  intact survivors.
Lactate concentrations of less than 7 mmol/L on admission or less than 8 mmol/L
at day 1 peak predicted survival with 82% sensitivity and 83% specificity, and
positive and negative predictive values of 97% and 43%, respectively (P  .001,
2). Plasma lactate concentrations were associated with adverse outcome but had
lower predictive values compared with that for nonsurvival.
Conclusions: Serial lactate determination accurately predicts survival and may help
differentiate survivors with adverse outcome from those with intact neurodevelop-
ment in early childhood.
Over the past 2 decades, the perioperative care of infants with complexcongenital heart disease has improved and led to decreased mortality.1Increasing attention is now being given to the outcome of infants surviving
after intracardiac surgery.2 Acute mortality during initial hospitalization usually relates
to the perioperative severity of the illness and is associated with multiorgan failure.3
However, the determinants of developmental outcome of infants surviving intracardiac
surgery are multifactorial, including brain injury before, during, and after surgery, as
well as environmental factors such as the socioeconomic status of the family.4
Intraoperative risk factors, such as the deep hypothermic circulatory arrest time5,6
and neuroimaging7 and electrophysiologic5,8 findings, have been shown to correlate
with mortality rates and neurodevelopmental morbidity after intracardiac surgery in
infants. Recently, in a prospective study of young infants (2 years of age) with
complex congenital heart disease excluding hypoplastic left heart syndrome (HLHS)
and other congenital anomalies, Limperopoulos and associates9 identified the fol-
lowing clinical characteristics that increase the risk for persistent developmental
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Ddeficits: preoperative and acute postoperative neurodevel-
opmental status, microcephaly, type of heart lesion, length
of deep hypothermic circulatory arrest, age at operation, and
days in the intensive care unit. Some of these factors,
however, are observer-dependent or occur late in the course
of initial hospitalization.
Plasma lactate is a conventional indicator of tissue hyp-
oxia10 and has been widely used in the management of
critically ill patients. Hyperlactatemia correlates with mor-
tality in adults, children, and neonates.11-14 After intracar-
diac surgery in young infants, the predictive value (PV) of
lactate concentration on postoperative mortality is sup-
ported by some studies,15-18 whereas Hatherill,19 Munoz,20
and their associates, both reported low positive PV (32%-
45%) for mortality despite an optimal sensitivity and spec-
ificity of approximately 80%. Although the discrepancy
may be related to developmental changes in lactate metab-
olism, a detailed examination of plasma lactate profile dur-
ing the postoperative period and its relationship with the
neurodevelopmental outcome in this population may help
establish its value in patient management.
To date, limited information is available on the relation-
ship between postoperative plasma lactate profile and the
outcome of neonates undergoing intracardiac surgery and
followed prospectively with comprehensive and standard-
ized neurodevelopmental assessment. In our previous report
on outcome predictors in a cohort of 85 infants, preliminary
findings suggested plasma lactate as an independent predic-
tor.21 Therefore, we investigated the PV of serial lactate
determination on the mortality and neurodevelopment in
early childhood of neonates with complex congenital heart
disease who underwent intracardiac surgery within 6 weeks
of age. We hypothesized that infants with persistently ele-
vated plasma lactate concentrations had a higher likelihood
of dying during the acute hospitalization period and had
abnormal neurodevelopmental outcome in early childhood
if they survived.
Patients and Methods
This study was approved by the Health Research Ethics Board of
the University of Alberta, Edmonton, Alberta, and the institutional
ethics committee of associated follow-up programs.
From September 1996 to August 1999, after informed consent,
all infants with complex congenital heart disease who were admit-
ted to the Stollery Children’s Hospital and who underwent intra-
cardiac surgery at the age of 6 weeks or less were prospectively
included in a multicenter cohort study to examine predictors as-
sociated with outcome.21 During the 3-year study period, 85 con-
secutively admitted, eligible infants (68% were male, 81% were
white) were enrolled in the study. Primary cardiac diagnoses
included transposition of great arteries with or without ventricular
septal defect (23, 27%), HLHS (26, 31%), total anomalous pul-
monary venous drainage (6, 7%), truncus arteriosus (9, 10%),
complex anomalies involving the aortic arch or mitral valve (16,
19%), and other complex cardiac lesion (5, 6%).
838 The Journal of Thoracic and Cardiovascular Surgery ● SeptAs part of the postoperative management of these sick infants,
plasma lactate concentrations were measured on or soon after
admission to the intensive care unit and frequently during the first
72 postoperative hours to assess tissue oxygenation. Any decision
to withdraw or discontinue treatment was not based solely on
plasma lactate concentration. Because this was a retrospective
analysis of convenient sampling of lactate levels, patients who had
normal lactate levels or died soon after admission had few lactate
determinations. The blood samples were preserved on ice, if not
run immediately, and sent for plasma lactate concentration assay
immediately by enzymatic spectrometric methods (normal range:
0.5-2.0 mmol/L). For this study, serial plasma lactate concentra-
tions of individual patients obtained during the entire postoperative
period were plotted on individual time-scaled charts for subse-
quent calculations as appropriate.
Multidisciplinary assessments were performed at 18 to 24
months of age at the Neonatal and Infant Follow-up Clinic at the
Glenrose Rehabilitation Hospital, Edmonton, Alberta (42%), or
associated follow-up clinics of the Western Canadian Complex
Pediatric Therapies Project (58%), with no knowledge of the
clinical course of these infants except for the intracardiac surgery.
The comprehensive assessment has been described.14,21 In brief,
Mental Developmental Index and Performance Developmental
Index were determined by the administration of Bayley Scales of
Infant Development22 by certified examiners with experience in
testing children with both normal and abnormal outcomes. Neu-
rologic and developmental examinations were completed by a
pediatrician experienced in neurodevelopmental follow-up. Behav-
ioral hearing tests were completed in a sound booth by a certified
clinical audiologist experienced in testing young children.
The following definitions were used in this study:
1. Nonsurvivor was defined as any infant who died during the
initial hospitalization, regardless of cause.
2. Adverse survivor was defined as an infant who died after
discharge from the hospital or who survived with motor or
sensory disability or neurodevelopmental delay. Disability
included the following: (1) cerebral palsy of all types or
severity23 that was diagnosed by a constellation of clinical
neuromotor abnormalities at 18 to 24 months as agreed by
2 physicians (a neurodevelopmental pediatrician and pedi-
atric neurologist/physiatrist); (2) legal blindness (corrected
visual acuity of the better eye 20/200); and/or (3) hearing
loss (sensorineural hearing of 40 dB in the better ear).
Neurodevelopmental delay was defined as either Mental
Developmental Index and/or Performance Developmental
Index greater than 2 SD below the mean for normative data
(70) without disability.
3. Intact survivor was defined as a survivor free of disability
and neurodevelopmental delay.
4. Adverse outcome referred to the combined group of non-
survivors and adverse survivors.
The clinical characteristics of the 3 study groups (nonsurvivors,
adverse and intact survivors) have been reported21 and are shown
in Table 1.
Data Handling of Postoperative Plasma Lactate Profile
For this study, plasma lactate concentration on admission to the
intensive care unit; peak postoperative concentration during hos-
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Dpitalization, day 1 (D1 peak), days 2 to 5, and 6 days after
intracardiac surgery; lactims; and area under the curve of the
lactate profile during postoperative day 1 were compared. Lactime
was defined as the time required for the plasma lactate concentra-
tion to decrease to 5 or 2 mmol/L or less. The area under the curve
was determined from the lactate profile and expressed in mmol/L · h.
Statistical Analysis
Data are expressed as mean  SD. Differences in the clinical and
biochemical measurements between the 3 groups (nonsurvivors,
adverse and intact survivors) were compared using 1-way analysis
of variance (ANOVA) followed by Scheffé multiple comparison
testing. To examine predictability of plasma lactate, concentrations
of 4 to 10 mmol/L and 15 mmol/L were used, based on the
available literature15-20 and general consensus of a poor chance of
survival, respectively. Their PVs for nonsurvival or adverse out-
come were calculated and analyzed with Fisher’s exact test. Com-
parison between 2 proportions was performed with the z test.
Statistical software programs, SPSS version 10.07 for Windows
(SPSS Inc, Chicago, Ill) and SigmaStat version 2.0 (Jandel Scien-
tific Corp, San Rafael, Calif), were used. Statistical significance
was set at P less than .05 except for post hoc Scheffé testing, which
was set at P less than .10 as recommended.
Results
Among 85 patients enrolled, 14 infants (16%) died during
the initial hospitalization after intracardiac surgery (4 on the
operative day, 2 between postoperative days 2 and 5, and 8
after postoperative day 5). Among these, 4 received extra-
corporeal membrane oxygenation postoperatively. The
causes of nonsurvival included multiple organ dysfunction
syndrome (10, 71%) and acute hemodynamic decompensa-
tion (4, 29%). Four children with HLHS (3) and transposi-
tion of great arteries (1) died of cardiorespiratory failure
before 18 months of age. The remaining 67 survivors re-
ceived follow-up at 18 to 24 months of age. Of the study
population, 28 children (33%) survived with adverse out-
TABLE 1. Demographic and clinical characteristics in 85 i
or less (mean  SD)
Nonsurvivo
N 14
Gestational age (wk)¶ 38 1
Birth weight (g) 3120 55
Apgar score at 1 min 7 1
Apgar score at 5 min 9 1
Age at intracardiac surgery (d) 13 12
Duration of CPB (min)¶ 157 82
Duration of hypothermic arrest (min)¶ 57 19
Crossclamp time (min) 69 21
Preoperative peak lactate (mmol/L) 3.9 4.3
Duration of hospitalization (d)¶ 30 25
CPB, Cardiopulmonary bypass. *P  .05 versus nonsurvivors, †P  .0
characteristics have been reported.21come including 4 late deaths and 24 with neurodevelopmen-
The Journal of Thoracital disability (3) or delay (21). Forty-three children (51%)
were considered intact survivors. The clinical characteris-
tics of the 3 study groups were not different (Table 1).
Survivors had shorter cardiopulmonary bypass times and
hypothermic arrest times than the nonsurvivors (Table 1).
During the early postoperative period, they also had higher
arterial pH than the nonsurvivors (7.36  0.08 and 7.33 
0.07 of the intact and adverse survivors, respectively, vs
7.26  0.13 of the nonsurvivors, P  .05, ANOVA),21 but
the PAO2 and base deficit were not different between groups
(data not shown).
Plasma Lactate Profile of Infants Treated With
Intracardiac Surgery
There were 8  4 (1-22) lactate determinations during the
first postoperative day with no differences between groups.
Infants of the nonsurvivor group had significantly higher
lactate concentrations on admission, at D1 peak, and during
hospitalization (highest concentrations) when compared
with the adverse and intact survivors, whose lactate concen-
trations were not different (Table 2). The lactate concentra-
tions on days 2 to 5 and 6 days after intracardiac surgery
were also higher in the nonsurvival group.21 Similar pat-
terns were observed in the subgroup of infants without
HLHS; for those with HLHS, nonsurvivors had significantly
longer lactime for plasma lactate concentration of 2 mmol/L
or less and higher peak lactate during hospitalization than
those of intact survivors. The nonsurvivor group also had
longer lactimes and greater area under the curve of the
lactate profile during day 1 after intracardiac surgery than
adverse and intact survivors (P  .001) (Table 2). Adverse
survivors had a significantly longer lactime for plasma
lactate concentration of 2 mmol/L or less than intact survi-
vors (Table 2). Two nonsurvivors (14%) had lactate con-
ts who underwent intracardiac surgery at 6 weeks of age
Adverse survivors Intact survivors
28 43
39 2 40  1
3280 750 3430 530
7  2 7  2
8  1 8  1
11 9 9 9
105 52* 97  29*,†
34 24* 25 24*
56 22 54 20
2.6 1.8 2.7  2.4
54 46 22 12
us adverse survivors (Scheffé, analysis of variance [ANOVA]). ¶Thesenfan
rs
0
5 verscentrations returned to 2 mmol/L or less within 24 hours
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and 37 intact survivors (86%).
Prediction of Outcome Using Plasma Lactate
To investigate whether plasma lactate had a practical prog-
nostic implication during the early postoperative period, we
examined the PVs of plasma lactate concentrations on ad-
mission and at D1 peak. The PVs of lactate concentrations
from 6 to 15 mmol/L, on admission and at D1 peak, on
nonsurvival are shown in Table 3. The relationship between
these plasma lactate concentrations and nonsurvival was
significant (Fisher exact test). Increasing the cutoff concen-
tration of plasma lactate decreases sensitivity and negative
PV but increases specificity and positive PV. Plasma lactate
concentrations of 15 mmol/L or greater on admission (but
not at D1 peak) provided a 100% specificity and positive PV
with poor sensitivity (Table 3). Optimal PVs were obtained
with plasma lactate concentrations of 7 mmol/L or greater
on admission or 8 mmol/L or greater at D1 peak (Table 4,
TABLE 2. Postoperative plasma lactate concentrations of i
or less (mean  SD)
Nonsurviv
N 14
On admission (mmol/L)* 10.7 4
Highest during day 1 (mmol/L)*,¶ 14.2 8
Highest during hospitalization (mmol/L)* 15.8 8
Lactime to 5 mmol/L (h)* 11 1
Lactime to 2 mmol/L (h)*,† 23 9
AUC of day 1 (mmol/L · h)* 220 2
AUC, Area under the curve. *P  .05 adverse or intact survivors versus n
intact survivors (Scheffé, ANOVA). Definitions of nonsurvivors and adverse
reported.21
TABLE 3. Prediction of nonsurvival in 85 infants who under
lactate concentrations (6-15 mmol/L) on admission and at
Sensitivity Specificity
Admission
6 mmol/L‡ 92% 56%
7 mmol/L‡ 92% 69%
8 mmol/L‡ 67% 82%
9 mmol/L‡ 58% 90%
10 mmol/L† 50% 96%
15 mmol/L‡ 25% 100%
D1 peak
7 mmol/L‡ 92% 63%
8 mmol/L‡ 83% 78%
9 mmol/L‡ 75% 79%
10 mmol/L* 50% 83%
11 mmol/L* 42% 86%
15 mmol/L‡ 33% 99%PV, Predictive value; D1, day 1. *P  .05, †P  .01, ‡P  .005 as related to th
840 The Journal of Thoracic and Cardiovascular Surgery ● SeptP  .001, Fisher’s exact test) (Figure 1). Lactate concen-
trations of 7 mmol/L or greater on admission and 8 mmol/L
or greater at D1 peak predicted nonsurvival with 83%
sensitivity and 82% specificity, which was higher than the
specificity with a lactate concentration of 7 mmol/L or
greater on admission (P  .07,   0.6, z test). The correct
prediction of outcome was 82%. Lactate concentrations of less
than 7 mmol/L on admission or less than 8 mmol/L at D1 peak
predicted survival with 82% sensitivity and 83% specificity,
and positive and negative PVs of 97% and 43%, respectively.
Plasma lactate determination was also significantly re-
lated to adverse outcome (Table 4, Fisher’s exact test).
Lactate concentration of 4 mmol/L or greater on admission
had a sensitivity or more than 80%, but low specificity,
which was significantly improved with D1 peak lactate
concentration of 6 mmol/L or greater (P .001, z test). The
use of either D1 peak lactate concentration of 6 mmol/L or
greater or combined lactate concentrations of 4 mmol/L or
ts who underwent intracardiac surgery at 6 weeks of age
Adverse survivors Intact survivors
28 43
6.3  2.4 5.5  2.6
6.8  3.4 6.2  3.6
7.9  4.6 6.5  3.7
4  4 3  6
16 10 11 9
80  30 70 50
vivors (Scheffé, analysis of variance [ANOVA]). †P  .07, adverse versus
tact survivors are described in the text. ¶These characteristics have been
t intracardiac surgery at 6 weeks of age or less by plasma
1 peak
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had similar PVs. The sensitivity was lower than that of
using lactate concentration on admission alone (P  .08, 
 0.6, z test). Compared with the PVs for nonsurvival, the
specificity and positive and negative PVs were significantly
lower for the prediction of adverse outcome (Table 3, z test).
The accuracy was also lower for the prediction of adverse
outcome (70%) than that of nonsurvival (P  .10,   0.6,
z test).
Discussion
Our study, based on a structured comprehensive follow-up
program, provides initial data supporting the PV of serial
Figure 1. Plasma lactate concentrations on admission and at day
1 peak of 85 infants with complex congenital heart disease who
underwent intracardiac surgery at 6 weeks of age or less. Lines
of admission lactate of 7 mmol/L and day 1 peak lactate of 8
mmol/L are placed for reference. Circles, normal survivors; trian-
TABLE 4. Predictive values of plasma lactate in 85 infants
Sens
Nonsurvival
Admission 7 mmol/L* 92
D1 peak 8 mmol/L* 83
Admission 7 mmol/L and D1 peak 8 mmol/L* 83
Adverse outcome
Admission 4 mmol/L† 85
D1 peak 6 mmol/L* 73
Admission 4 mmol/L and D1 peak 6 mmol/L* 73
PV, Predictive value; D1, day 1. *P  .001, †P  .05 as related to the outco
PV for adverse outcome, z test. ¶P  .001 versus the corresponding PV ugles, adverse survivors; diamonds, nonsurvivors.
The Journal of Thoraciplasma lactate determination in young infants undergoing
intracardiac surgery at an age of 6 weeks or less. It has been
suggested that neonates requiring intracardiac surgery are at
a higher risk for neurodevelopmental disabilities than older
children.9 Several studies have demonstrated an association
between hyperlactatemia and mortality after intracardiac
surgery in children.12,15-20 Our findings support the use of
plasma lactate concentrations to predict early survival with
an accuracy of more than 80%. Specifically, plasma lactate
of less than 7 mmol/L on admission or less than 8 mmol/L
at D1 peak predicts survival with a positive PV of 97% in
contrast with the prediction of nonsurvival with a positive
PV of only 43% for plasma lactate exceeding these levels.
In addition, serial plasma lactate determination may help
identify those survivors with neurodevelopmental disability
or delay as having a longer lactime for the lactate concen-
tration to decrease to 2 mmol/L or less during the first
postoperative day than did the intact survivors. Plasma
lactate measurement, which is readily available in all hos-
pitals, has the potential to objectively provide predictive
information on the outcome of these critically ill neonates
during the early postoperative period.
The PV of plasma lactate on mortality has been exten-
sively studied in critically ill adults, but less so in the
pediatric population. Several studies confirmed the PV of
hyperlactatemia in selected groups of neonates, including
those with severe hypoxemia24 or hypoxemic-ischemic en-
cephalopathy,13 and after extracorporeal membrane oxygen-
ation.14 Our results support the use of plasma lactate as an
early predictor of outcome in a selected population of crit-
ically ill neonates and adds to the literature on predictors of
mortality in neonates after intracardiac surgery.12,15-20 The
nonsurvivors had higher plasma lactate on admission and at
D1 peak after intracardiac surgery. Although similar pat-
terns were observed in the subgroup of infants without
HLHS and to a lesser extent for those with HLHS, our
sample size was too small for further analysis of individual
cardiac defects. As shown by the lactimes, nonsurvivors
also had a slower rate of decline in plasma lactate postop-
underwent intracardiac surgery at 6 weeks of age or less
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Dates20 in 174 children undergoing operations for congenital
heart disease. Munoz and colleagues20 also noted that hy-
perlactatemia during cardiopulmonary bypass in 174 pa-
tients with intracardiac surgery was associated with postop-
erative mortality. Charpie and coworkers15 suggested that
serial lactate determination might be an accurate predictor
of death within 72 hours postoperatively or requirement for
extracorporeal membrane oxygenation support in a prospec-
tive study of 46 infants who underwent complex neonatal
cardiac surgery.
Siegel and colleagues12 reported high PVs of lactate
concentration in 41 children with intracardiac surgery and
indicated that using an admission lactate concentration of
greater than 4.2 mmol/L predicted postoperative deaths with
a positive PV of 100%. In a study with results similar to
ours, Hatherill and associates19 reported that an initial lac-
tate concentration of greater than 6 mmol/L had poor pos-
itive PV (32%) for mortality in a prospective observational
study of 99 young children aged 0.38 to 31 months. How-
ever, by using admission lactate of 7 mmol/L or greater, we
reported higher sensitivity (vs 78%), lower specificity (vs
83%), and similar negative PV (vs 97%). Nonetheless, the
overall accuracy of prediction is similar between studies at
greater than 80%. The “poor” positive PV may undermine
the usefulness of plasma lactate concentration to identify
nonsurvivors because of other confounding issues and ad-
vances in surgical and perioperative care, which may ex-
plain the different and apparent contrasting observations
between studies and surgical populations. Indeed, the pos-
itive PV value remains less than 100% despite lactate con-
centrations 15 mmol/L or greater, which may indicate a
dismal chance of survival (Table 3). With recognition of this
weakness, plasma lactate concentration may predict which
infants survive the immediate postoperative course after
intracardiac surgery. Lactate concentrations of 7 mmol/L
or less on admission or 8 mmol/L or less at D1 peak
predicts survival accurately, with a sensitivity of 82% and a
positive PV of 97% as shown in our study. Furthermore,
although there is a wide range of plasma lactate concentra-
tions used in the prediction (4-7 mmol/L),12,15-20 the lactate
concentration used in our study is consistent with others
reporting a mortality of 10% or more.18,19 Indeed, Munoz
and coworkers20 observed an association between the com-
plexity of intracardiac surgery and the lactate concentration.
Therefore, a heterogeneous population of infants with in-
tracardiac surgery may explain the variation in the lactate
concentrations used in prediction that may need modifica-
tion according to institutional experience.
Predicting the neurodevelopmental outcome in critically
ill neonates is difficult. From our previous report, almost
40% of the total variance of the long-term outcome re-
mained unaccounted for by known risk factors identified
during the preoperative, intraoperative, and postoperative
842 The Journal of Thoracic and Cardiovascular Surgery ● Septperiods.21 Nonetheless, various risk factors including the
deep hypothermic circulatory arrest time,6 neuroimaging,7
and electrophysiologic8 findings, and certain clinical fea-
tures9 have been shown to be associated with subsequent
neurodevelopmental outcome after intracardiac surgery.
The current study is the first we are aware of to examine the
PV of plasma lactate on neurodevelopmental outcome in
early childhood after intracardiac surgery. This provides an
objective assessment that is available early in the course
after intracardiac surgery. However, consistent with our
previous observation in those neonates requiring extracor-
poreal membrane oxygenation,14 the PVs for adverse out-
come are lower than those for early mortality. Although
mortality is usually related to the extent of organ failure or
irreversible dysfunction of multiple organs, which may be
reflected in the plasma lactate concentration, the plasma
lactate concentration may not indicate the severity of organ-
specific hypoxia. Therefore, plasma lactate determination has
a lower predictability of the degree of cerebral hypoxemic-
ischemic insult in patients with nonlethal systemic hypoxemia.
We suggest that serial lactate determination including a
detailed examination of the lactate profile may help predict
adverse outcome soon after admission to the intensive care
unit with an accuracy of 70%. Indeed, the use of lactate
concentrations on postoperative days 2 to 5 after cardiac
surgery significantly improved the prediction of neurode-
velopmental outcome of these patients.21
In this study, we used the definitions of lactime and area
under the curve for the lactate profile in similar fashion to
the report by Bakker and coworkers.24 Bakker’s group used
the lactime for plasma lactate concentration to decrease to 2
mmol/L or less. They also calculated the theoretical area
under the curve assuming a linear regression of the lactate
concentration in contrast with our direct measurement using
the lactate profile charted individually. In this study, we
provided a detailed examination of the role of lactime and a
more accurate estimation of the area under the curve of the
lactate profile to examine the PV of serial lactate determi-
nation. Furthermore, it is important to study the PV of
lactate concentrations in neonates rather than in a heteroge-
neous population of different developmental ages. Lactate
metabolism is influenced by developmental changes includ-
ing maturation of liver enzymes involved in the glucose
hexaphosphate shunt. This may explain the high lactate
concentrations during the immediate perinatal period that
decrease with increasing age.25 Indeed, because of these
developmental changes, a careful interpretation of the lac-
tate concentration profile rather than individual values is
warranted, as suggested by Saugstad.26
Conclusion
In addition to its conventional use as a biochemical marker
of tissue oxygenation for the management of critically ill
ember 2005
Cheung et al Surgery for Congenital Heart Diseaseneonates, plasma lactate can also be used as an early out-
come predictor, particularly of survival, for neonates with
complex congenital heart disease who undergo intracardiac
surgery within 6 weeks of age. Further multicenter studies
are required to confirm our observations and to examine the
value of plasma lactate in the decision-making process.
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